Viewing StudyNCT00378690



Ignite Creation Date: 2024-05-05 @ 5:02 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00378690
Status: COMPLETED
Last Update Posted: 2014-06-04
First Post: 2006-09-19

Brief Title: A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD
Sponsor: Astellas Pharma Inc
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
Prostate Specific Antigen View
Prostate Cancer View